QX39

http://dbpedia.org/resource/QX39 an entity of type: Thing

QX39 (Compound A, CA39) is a synthetic compound that activates chaperone-mediated autophagy (CMA) by increasing the expression of the lysosomal receptor for this pathway, LAMP2A lysosomes. It showed potent activity in vitro but has poor pharmacokinetic properties and was not suitable for animal research. Subsequent research led to the development of CA77.1, a CMA activator suitable for in vivo use. rdf:langString

rdfs:label

rdf:langString QX39

foaf:name

rdf:langString QX39

dbpedia-owl:wikiPageID

xsd:integer 67626578

dbpedia-owl:wikiPageRevisionID

xsd:integer 1092545277

dbpprop:c

xsd:integer 20

dbpprop:casNumber

xsd:integer 1798331

dbpprop:cl

xsd:integer 1

dbpprop:drugName

rdf:langString QX39

dbpprop:h

xsd:integer 14

dbpprop:iupacName

rdf:langString N-acetamide

dbpprop:n

xsd:integer 1

dbpprop:o

xsd:integer 1

dbpprop:pubchem

xsd:integer 91809172

dbpprop:smiles

rdf:langString C1CC3=CC=CC4=CC=CC=C4

dbpprop:stdinchi

xsd:integer 1

dbpprop:stdinchikey

rdf:langString RJFBVAUZKPHMJI-UHFFFAOYSA-N

dbpedia-owl:abstract

rdf:langString QX39 (Compound A, CA39) is a synthetic compound that activates chaperone-mediated autophagy (CMA) by increasing the expression of the lysosomal receptor for this pathway, LAMP2A lysosomes. It showed potent activity in vitro but has poor pharmacokinetic properties and was not suitable for animal research. Subsequent research led to the development of CA77.1, a CMA activator suitable for in vivo use.

dbpedia-owl:wikiPageLength

xsd:nonNegativeInteger 3133

dbpedia-owl:casNumber

xsd:string 1798331-71-1

dbpedia-owl:pubchem

xsd:string 91809172

rdf:type

owl:Thing

<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject>

dbpedia-owl:ChemicalSubstance

<http://www.wikidata.org/entity/Q8386>

dbpedia-owl:Drug